Evidence map›Paper›PMID 24286856›Full record

ArticleMetabolism: clinical and experimental2014

Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.

Robert A Egnatchik, Alexandra K Leamy, Yasushi Noguchi, Masakazu Shiota, Jamey D Young

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 159 citations in OpenAlex.

  1. Treatment with saponins fromNutrition research and practice · 2026
    Article
  2. Advances in Lipid Metabolism Reprogramming in Hepatocellular Carcinoma.Journal of clinical and translational hepatology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective.Advances in experimental medicine and biology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of Oxidative Stress on Insulin Resistance in Diet-Induced Obesity Mice.International journal of molecular sciences · 2023
    Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Robert A EgnatchikChemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Alexandra K LeamyChemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Yasushi NoguchiInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Japan.
Masakazu ShiotaMolecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
Jamey D YoungChemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA; Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA. Electronic address: j.d.young@vanderbilt.edu.
Vanderbilt University · USAjinomoto (Japan) · JP

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
NIDDK NIH HHS DK020593NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P60 DK020593
6 · The paper itself

Abstract

objectiveHepatic lipotoxicity is characterized by reactive oxygen species (ROS) accumulation, mitochondrial dysfunction, and excessive apoptosis, but the precise sequence of biochemical events leading to oxidative damage and cell death remains unclear. The goal of this study was to delineate the role of mitochondrial metabolism in mediating hepatocyte lipotoxicity. MATERIALS/

methodsWe treated H4IIEC3 rat hepatoma cells with free fatty acids in combination with antioxidants and mitochondrial inhibitors designed to block key events in the progression toward apoptosis. We then applied (13)C metabolic flux analysis (MFA) to quantify mitochondrial pathway alterations associated with these treatments.

resultsTreatment with palmitate alone led to a doubling in oxygen uptake rate and in most mitochondrial fluxes. Supplementing culture media with the antioxidant N-acetyl-cysteine (NAC) reduced ROS accumulation and caspase activation and partially restored cell viability. However, (13)C MFA revealed that treatment with NAC did not normalize palmitate-induced metabolic alterations, indicating that neither elevated ROS nor downstream apoptotic events contributed to mitochondrial activation. To directly limit mitochondrial metabolism, the complex I inhibitor phenformin was added to cells treated with palmitate. Phenformin addition eliminated abnormal ROS accumulation, prevented the appearance of apoptotic markers, and normalized mitochondrial carbon flow. Further studies revealed that glutamine provided the primary fuel for elevated mitochondrial metabolism in the presence of palmitate, rather than fatty acid beta-oxidation, and that glutamine consumption could be reduced through co-treatment with phenformin but not NAC.

conclusionOur results indicate that ROS accumulation in palmitate-treated H4IIEC3 cells occurs downstream of altered mitochondrial oxidative metabolism, which is independent of beta-oxidation and precedes apoptosis initiation.

Indexed as

ApoptosisOxidative StressAcetylcysteineAnimalsAntioxidantsCarbon IsotopesCarcinoma, HepatocellularCaspases, EffectorCell Line, TumorEnzyme ActivationHepatocytesLiver NeoplasmsMetabolic Flux AnalysisMitochondria, LiverPalmitatesRatsAcetylcysteineAntioxidantsCarbon IsotopesCaspases, EffectorPalmitatesReactive Oxygen Species2′-7′-dichlorodihydrofluorescein diacetatebovine serum albuminBSACACcitric acid cycleEtoetomoxirFFAfree fatty acidgas chromatography–mass spectrometryGC-MSH(2)DCFDAIsotopomer modelingLipotoxicityMass spectrometrymetabolic flux analysisMetabolic flux analysisMFAmonounsaturated fatty acidMUFANACN-acetyl cysteineNAFLDNASHnon-alcoholic fatty liver diseasenon-alcoholic steatohepatitisOAoleatePApalmitatePHENphenforminPIpropidium iodidereactive oxygen speciesReactive oxygen speciesROSsaturated fatty acid.SFA

Identifiers

PMID24286856
PMCPMC3946971
OpenAlexW2006241936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.